Hematology/Oncology Topics
RSSArticles
-
Sickle Cell Disease in the Emergency Department
Sickle cell disease is a complex condition with diverse potential complications. In the emergency department setting, physicians should be aware of the life-threatening pathologies that can affect patients with sickle cell disease.
-
Momelotinib Tablets (Ojjaara)
Momelotinib can be prescribed to treat intermediate- or high-risk myelofibrosis.
-
Pediatric Hematology/Oncology Trainees Want Ethics Expertise
Ethics education would not replace the option or need to obtain a formal ethics consultation. However, such education could lead to fewer cases during which specialists believe they need such assistance.
-
Physician Group Says to Start Colon Cancer Screening at Age 50 Years
Patient advocates push back, standing by other recommendations that set the age at 45 years.
-
Reconsidering Aspirin Therapy for Elderly Patients
A post-hoc analysis of the ASPREE trial revealed that in presumably healthy elderly subjects, taking low-dose aspirin daily over three years was associated with a significant drop in hemoglobin and ferritin levels vs. placebo, even when patients with major bleeding events were excluded.
-
U.S. Funding Targets Cancer Rates in Low-Income Neighborhoods
National Cancer Institute to manage a $50 million program to address structural and institutional factors of poverty related to cancer.
-
Ethical Considerations When Using Gene-Editing Treatment for Sickle Cell Disease
Like any other treatment, it is important patients are aware of limitations, but without crushing their hopes that a cure might be feasible.
-
Advance Care Planning Can Lower Odds of Aggressive End-of-Life Treatment
Advance care planning was associated with significantly lower odds of indicators of aggressive end-of-life care (i.e., hospital death, hospital admissions, intensive care, delayed hospice referrals, and chemotherapy). Cancer patients who engaged in advance care planning were 50% more likely to complete Do Not Resuscitate orders compared to cancer patients without an advance directive.
-
EPA Moving to Reduce Cancer Risk to HCWs Exposed to EtO Sterilant
Ethylene oxide (EtO) is used on approximately 50% of all sterilized medical devices annually, including an estimated 95% of all surgical kits. EtO can sterilize heat- or moisture-sensitive medical equipment without causing any damage. Proposed regulations from the Environmental Protection Agency are designed to sharply reduce worker exposures to EtO sterilant and prevent occupational cancer.
-
Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (Altuviiio)
Altuviiio can be prescribed to adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes, and perioperative bleeding management.